Table 4.
Comparison of variables between baseline and end point in subjects who developed non-alcoholic fatty liver disease
| Variables | Difference | t value | P value |
| BMI (kg/m2) | -1.454 | -17.198 | 0.000 |
| SBP (mmHg) | -4.875 | -6.105 | 0.000 |
| DBP (mmHg) | -2.225 | -4.021 | 0.000 |
| Hb (g/L) | -3.537 | -6.972 | 0.000 |
| PLT (× 109/L) | -7.352 | -3.276 | 0.001 |
| WBC (× 109/L) | -0.283 | -3.728 | 0.000 |
| SUA (μmol/L) | -29.304 | -8.814 | 0.000 |
| FPG (mmol/L) | -0.463 | -10.909 | 0.000 |
| TG (mmol/L) | -0.224 | -2.630 | 0.009 |
| TC (mmol/L) | -0.268 | -6.823 | 0.000 |
| LDL (mmol/L) | 0.054 | 1.368 | 0.172 |
| VLDL (mmol/L) | -0.295 | -11.043 | 0.000 |
| HDL (mmol/L) | 0.126 | 10.200 | 0.000 |
| ALT (U/L) | -3.099 | -2.672 | 0.008 |
| AST (U/L) | 0.006 | 0.009 | 0.993 |
| γ-GT (U/L) | -10.43 | -4.912 | 0.000 |
BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; Hb: Hemoglobin; PLT: Platelet; WBC: White blood cell; SUA: Serum uric acid; FPG: Fasting plasma glucose; TG: Triglycerides; TC: Total cholesterol; LDL: Low-density lipoprotein; VLDL: Very low-density lipoprotein; HDL: High-density lipoprotein; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; γ-GT: Gamma-glutamyl transpeptidase.